Holland Johnson

Atlanta

Executive Editor at BioWorld

Executive Editor at BioWorld MedTech

Executive Editor of Medical Device Daily, the daily medical technology news source. Lover of all things Georgia Bulldog-related. Avid outdoor enthusiast.

Featured in: Favicon

bioworld.com

Articles

In TAVR setback, Boston Sci pulls plug on Acurate valves

1 week ago | bioworld.com | Holland Johnson

Home » In TAVR setback, Boston Sci pulls plug on Acurate valvesIn TAVR setback, Boston Sci pulls plug on Acurate valvesBoston Scientific Corp. reported the latest setback in its transcatheter aortic valve replacement (TAVR) aspirations with the news that it is officially discontinuing worldwide sales of its Acurate neo2 and Acurate Prime systemsBioWorld MedTech Clinical Cardiovascular TAVR U.S. FDA
Survey says AI must overcome trust issue to transform health care

3 weeks ago | bioworld.com | Holland Johnson

Home » Survey says AI must overcome trust issue to transform health careSurvey says AI must overcome trust issue to transform health careRoyal Philips NV unveiled its Future Health Index report for 2025, and it reveals the widening trust gap between health care professionals and patients concerning the adoption of AI in health care. BioWorld MedTech Artificial intelligence Digital health Asia-Pacific Europe U.S.
J&J reports completion of first cases with Ottava robotic system

1 month ago | bioworld.com | Holland Johnson

J&J reports completion of first cases with Ottava robotic systemJohnson & Johnson’s Medtech division reported the completion of the first cases in the clinical trial for the Ottava robotic surgical system. The cases mark the first clinical experience with the Ottava system, which has been a long time in development. BioWorld MedTech Clinical Regulatory Gastrointestinal Robotic surgery U.S. De novo FDA
Vivani looking to get slim with Cortigent neurostimulation spin

2 months ago | bioworld.com | Holland Johnson

Home » Vivani looking to get slim with Cortigent neurostimulation spinVivani looking to get slim with Cortigent neurostimulation spinThe Vivani Medical Inc. combination appears to be over less than three years since its inception after the company reported plans to spin off Cortigent, the division that develops brain implants. BioWorld Deals and M&A Diabetes Neurology/psychiatric Deep brain stimulation U.S.
Vivani looking to slim with Cortigent neurostimulation spin

2 months ago | bioworld.com | Holland Johnson

At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
SCAAR data Prevails for Medtronic paclitaxel-coated balloon

2 months ago | bioworld.com | Holland Johnson

SCAAR data Prevails for Medtronic paclitaxel-coated balloonMedtronic plc reported results from a registry highlighting the effectiveness of the Prevail paclitaxel-coated balloon. The findings from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) were presented by Sacharias von Koch of the department of cardiology and clinical sciences at Lund University, Skåne University Hospital in Sweden at the Cardiovascular Research Technologies 2025 meeting in Washington.
Medtronic sees SMART TAVR results in small aortic annulus patients

2 months ago | bioworld.com | Holland Johnson

Medtronic sees SMART TAVR results in small aortic annulus patientsMedtronic plc released positive results from a two-year trial of Evolut TAVR that demonstrated superior valve performance in patients with small aortic annuli. The SMall Annuli Randomized To Evolut or SAPIEN trial assessed patients with aortic stenosis and a small aortic annulus.
Repligen buying 908 Devices’ Bioprocess Analytics portfolio

Mar 6, 2025 | bioworld.com | Holland Johnson

Home » Repligen buying 908 Devices’ Bioprocess Analytics portfolio On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his... BioWorld briefs for March 6, 2025. BioWorld MedTech briefs for March 5, 2025 Roche Holding AG revealed plans to launch its sequencing by expansion technology next year, raising the possibility that rival Illumina Inc. could face a real run...
Tandem wins FDA clearance for automated insulin delivery system

Feb 27, 2025 | bioworld.com | Holland Johnson

Tandem wins FDA clearance for automated insulin delivery systemTandem Diabetes Care Inc. reported that its next-generation automated insulin delivery algorithm, Control-IQ+ technology (Control-IQ+), is cleared by the U.S. FDA for use by people with type 2 diabetes (T2D) ages 18 and older. Control-IQ+, already cleared for use by people with type 1 diabetes, builds on the company’s Control-IQ algorithm and includes enhancements to accommodate input of expanded weight and total daily insulin ranges.
Raft of FDA job cuts may slow med-tech approvals

Feb 21, 2025 | bioworld.com | Holland Johnson

Raft of FDA job cuts may slow med-tech approvalsIn response to the news of reported layoffs at the U.S. FDA over the weekend, Advanced Medical Association president and CEO Scott Whitaker said in press release that these “significant job cuts could have a very negative impact on patient care in this country.”BioWorld MedTech Clinical Regulatory U.S. FDA Policy